Sanofi and Regeneron’s Dupixent recommended for EU approval to treat chronic spontaneous urticaria in young children with ongoing symptoms despite treatment If approved, Dupixent would be the first ta ...
The Marine Corps just killed height-and-weight screenings. A completely new method is now the standard for every Marine's ...
Acoziborole Winthrop, developed by DNDi and Sanofi, receives CHMP positive opinion as three-tablet, single-dose treatment for most common form of sleeping sickness Recommendation based on phase 2/3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results